| Dr Laura Kay Wade, MD | |
|
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Dr Laura Kay Wade |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 820 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851376560 | NPI | - | NPPES |
| 00C516390 | Medicaid | CA | |
| 201188245 | Other | CA | TRICARE WEST REGION |
| 610735200 | Other | CA | FECA |
| 201188245 | Other | CA | BLUE SHIED CA |
| 201188245 | Other | CA | BLUE CROSS |
| P00149731 | Other | CA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C51639 (California) | Secondary |
| 207Q00000X | Family Medicine | C516390 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Kay Wade, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Dr Laura Kay Wade, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 |
News Archive
Scientists at the University of Maryland, Baltimore have successfully used near-infrared spectroscopy (NIR) - a method already used to test farm product quality - to predict how quickly pills dissolve in the body.
AOI Medical, Inc. has received ISO 13485 Certification and CE marking approval for its Ascendx VCF Repair System and its Ascendx Acu-Cut Vertebral Augmentation System to treat vertebral compression fractures (VCF).
Children's health advocates are concerned that a new health reform proposal by the Senate Finance Committee could jeopardize coverage of many low-income children now insured by the State Children's Health Insurance Program, which expires in 2013, Politico reports.
TearScience, a privately-held medical device company, today announced the completion of $44.5 million of Series C funding from new investors Essex Woodlands Health Ventures, Investor Growth Capital and General Catalyst. The company's existing investors, De Novo Ventures, Spray Ventures and Quaker Bio Ventures completed the round. The funding will allow TearScience to commercialize its devices designed for use by eye care professionals to diagnose and treat the most common form of chronic dry eye disease.
A collaboration, led by scientists at the Garvan Institute of Medical Research and the University of New South Wales (UNSW) in Sydney, has discovered the first risk gene specifically for bipolar disorder, also known as manic-depressive illness. This means that people who have a particular form of this gene are twice as likely to develop the disease.
› Verified 7 days ago
Andrew G Eichler, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 N Emerson Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Carolyn R Johnson, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 600 Orondo Ave, Ste 1, Wenatchee, WA 98801 Phone: 509-662-6000 Fax: 509-664-4588 | |
Richard J Beukema, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Orondo Ave 1, Wenatchee, WA 98801 Phone: 509-662-6000 Fax: 509-664-4590 | |
Donald R Murphy, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Patricia Ortiz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Scott E Lamb, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Orondo Ave, Ste 1, Wenatchee, WA 98801 Phone: 509-662-6000 Fax: 509-664-4588 | |
Sara J. Norris, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Orondo Ave, Wenatchee, WA 98801 Phone: 509-662-6000 |